Jeffrey S. McCombs, PhD
Clinical Pharmacy and Pharmaceutical Economics & Policy
Fax: (323) 442-1462
Health economics, technology assessment, competitive pricing systems, retrospective analyses using administrative data, mental health economics.
Ph.D. in Economics, University of California, San Diego, 1982.
Assistant Professor, Department of Mental Hygiene, School of Hygiene and Public Health, The Johns Hopkins University, 1980-1982.
Senior Project Analyst, Applied Management Sciences, Silver Springs, MD, 1982-83.
Social Science Research Analysis, Office of Research and Demonstrations, Health Care Financing Administration, 1983-1987.
USC School of Pharmacy, Department of Pharmaceutical Economics and Policy, 1987-present.
Click here for:
McCombs JS: Impact of Atypical Antipsychotics on Patient Outcomes and Treatment Costs for Patients with Schizophrenia and Bipolar Disorders. 12/15/06-12/14/07, Bristol-Myers Squibb, $194,310.
McCombs JS: Retrospective research designs: Emulating experimental research or playing games? 12/01/05-11/30/06, Eli Lilly and Company, $80,000.
McCombs JS and Ahn J: Classification of antipsychotic non-adherence in patients with schizophrenia: A case mix analysis. 12/04-4/05. Eli Lilly and Company, $61,973.
McCombs, JS: The Impact of Antidepressant Drug Therapy for Patients with Bipolar Disorders: An Extension of Data Retrieval and Analysis. Eli Lilly and Company, 02/01/03-01/31/05, $100,500.
Selected Projects/PublicationsChen l, McCombs JS, Park JX. Duration of antipsychotic drig therapy in real world practice: A comparison with CATIE trial results. Value in Health 2007 (in press).
Chen L, McCombs JS, Park JX. The impact of atypical antipsychotic medications on the use of health care by patient with schizophrenia. Value in Health 2007 (in press).
Ahn J, McCombs JS, Jung C, et al. Classifying antipsychotic adherence using latent class analysis: Characteristics of non-adherent patients in the California Medicaid (Medi-Cal)Program. Value in Health 2007 (in press).
McCombs JS, Ahn J, Tencer T, Shi L. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: A 6-year retrospective analysis. Journal of Affective Disorders 2007;97:171-179.
Shi L, Thiebaud P, McCombs JS. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-service California Medicaid (Medi-Cal) Program. Journal of Affective Disorders 2004; 82:373-383.